Please enable JavaScript to continue using this application.

Compare $IMUX vs $PMVP | Chartloom

Compare

$IMUX vs $PMVP

Immunic Inc · PMV Pharmaceuticals Inc

IMUX

Immunic Inc

PMVP

PMV Pharmaceuticals Inc

Compare $IMUX vs $PMVP

Comparing Immunic Inc and PMV Pharmaceuticals Inc

IMUXImmunic Inc

PMVPPMV Pharmaceuticals Inc

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

PMVPPMV Pharmaceuticals Inc

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.6%

52W performance

7.0%

FCF yield

-87.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUX

PMVP

Detailed metrics comparison

IMUX

Immunic Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

IMUX$112M

PMVP$81M

Enterprise Value

IMUX$-44M

PMVP$69M

Price

IMUX$8.19

PMVP$1.52

P/E Ratio

IMUXN/A

PMVPN/A

P/S Ratio

IMUX0.00x

PMVP0.00x

EV/Sales

IMUX0.00x

PMVP0.00x

EV/EBITDA

IMUX0.00x

PMVP0.00x

P/B Ratio

IMUX0.85x

PMVP1.89x

P/FCF Ratio

IMUXN/A

PMVPN/A

EV/FCF

IMUX0.49x

PMVP-0.96x

PEG Ratio

IMUXN/A

PMVPN/A

Forward P/E (NTM)

IMUXN/A

PMVPN/A

Forward P/S (NTM)

IMUXN/A

PMVPN/A

Revenue (TTM)

IMUX$0

PMVP$0

Revenue Growth (YoY)

IMUXN/A

PMVPN/A

Forward Rev Growth

IMUX650.4%

PMVP546.2%

Gross Margin (TTM)

IMUX0.0%

PMVP0.0%

Operating Margin (TTM)

IMUX0.0%

PMVP0.0%

EBITDA Margin (TTM)

IMUX0.0%

PMVP0.0%

Net Margin (TTM)

IMUX0.0%

PMVP0.0%

FCF Margin (TTM)

IMUXN/A

PMVPN/A

Net Income (TTM)

IMUX$-112M

PMVP$-75M

FCF (TTM)

IMUX$-88M

PMVP$-71M

EPS (TTM)

IMUX-$2.62

PMVP-$1.41

ROE (TTM)

IMUX-9567.0%

PMVP-7811.0%

ROA (TTM)

IMUX-10788.0%

PMVP-7013.0%

ROIC (TTM)

IMUX-9567.0%

PMVP-7811.0%

Cash

IMUX$155M

PMVP$12M

Debt

IMUX$0

PMVP$0

Net Cash/Debt

IMUX$155M

PMVP$12M

Current Ratio (TTM)

IMUX5.05x

PMVP7.70x

Quick Ratio (TTM)

IMUX5.00x

PMVP7.52x

Debt/Equity (TTM)

IMUX0.00x

PMVP0.00x

Debt/Assets (TTM)

IMUX0.0%

PMVP0.0%

Interest Coverage (TTM)

IMUXN/A

PMVPN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

PMVP0.00x

Beta

IMUX1.47

PMVP1.48

52W Performance

IMUX-8.8%

PMVP7.0%

YTD Performance

IMUX40.5%

PMVP23.6%

% from 52W High

IMUX-53.0%

PMVP-20.4%

% from 52W Low

IMUX61.9%

PMVP49.0%

Asset Turnover (TTM)

IMUX0.00x

PMVP0.00x

FCF Yield (TTM)

IMUX-78.9%

PMVP-87.9%

Earnings Yield (TTM)

IMUX-100.0%

PMVP-92.8%

Dividend Yield (TTM)

IMUXN/A

PMVPN/A

Rule of 40

IMUX0.0

PMVP0.0

EV/GP/RG

IMUXN/A

PMVPN/A

Ticker research

View IMUX research View PMVP research

Metric	IMUX Immunic Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$112M	$81M
Enterprise Value	$-44M	$69M
Price	$8.19	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.4%	546.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-112M	$-75M
FCF (TTM)	$-88M	$-71M
EPS (TTM)	-$2.62	-$1.41
ROE (TTM)	-9567.0%	-7811.0%
ROA (TTM)	-10788.0%	-7013.0%
ROIC (TTM)	-9567.0%	-7811.0%
Financial Health
Cash	$155M	$12M
Debt	$0	$0
Net Cash/Debt	$155M	$12M
Current Ratio (TTM)	5.05x	7.70x
Quick Ratio (TTM)	5.00x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.48
52W Performance	-8.8%	7.0%
YTD Performance	40.5%	23.6%
% from 52W High	-53.0%	-20.4%
% from 52W Low	61.9%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-78.9%	-87.9%
Earnings Yield (TTM)	-100.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View PMVP research

Valuation

P/S Ratio

IMUX

0.00x

PMVP

0.00x

EV/FCF

PMVP

-0.96x

IMUX

0.49x

Growth & revenue

Forward Revenue Growth

IMUX

650.4%

PMVP

546.2%

Profitability & performance

Gross Margin

IMUX

0.0%

PMVP

0.0%

ROE

PMVP

-7811.0%

IMUX

-9567.0%

FCF Yield %

IMUX

-78.9%

PMVP

-87.9%

52-Week Performance

PMVP

7.0%

IMUX

-8.8%

Detailed metrics comparison

IMUX

Immunic Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

IMUX$112M

PMVP$81M

Enterprise Value

IMUX$-44M

PMVP$69M

Price

IMUX$8.19

PMVP$1.52

P/E Ratio

IMUXN/A

PMVPN/A

P/S Ratio

IMUX0.00x

PMVP0.00x

EV/Sales

IMUX0.00x

PMVP0.00x

EV/EBITDA

IMUX0.00x

PMVP0.00x

P/B Ratio

IMUX0.85x

PMVP1.89x

P/FCF Ratio

IMUXN/A

PMVPN/A

EV/FCF

IMUX0.49x

PMVP-0.96x

PEG Ratio

IMUXN/A

PMVPN/A

Forward P/E (NTM)

IMUXN/A

PMVPN/A

Forward P/S (NTM)

IMUXN/A

PMVPN/A

Revenue (TTM)

IMUX$0

PMVP$0

Revenue Growth (YoY)

IMUXN/A

PMVPN/A

Forward Rev Growth

IMUX650.4%

PMVP546.2%

Gross Margin (TTM)

IMUX0.0%

PMVP0.0%

Operating Margin (TTM)

IMUX0.0%

PMVP0.0%

EBITDA Margin (TTM)

IMUX0.0%

PMVP0.0%

Net Margin (TTM)

IMUX0.0%

PMVP0.0%

FCF Margin (TTM)

IMUXN/A

PMVPN/A

Net Income (TTM)

IMUX$-112M

PMVP$-75M

FCF (TTM)

IMUX$-88M

PMVP$-71M

EPS (TTM)

IMUX-$2.62

PMVP-$1.41

ROE (TTM)

IMUX-9567.0%

PMVP-7811.0%

ROA (TTM)

IMUX-10788.0%

PMVP-7013.0%

ROIC (TTM)

IMUX-9567.0%

PMVP-7811.0%

Cash

IMUX$155M

PMVP$12M

Debt

IMUX$0

PMVP$0

Net Cash/Debt

IMUX$155M

PMVP$12M

Current Ratio (TTM)

IMUX5.05x

PMVP7.70x

Quick Ratio (TTM)

IMUX5.00x

PMVP7.52x

Debt/Equity (TTM)

IMUX0.00x

PMVP0.00x

Debt/Assets (TTM)

IMUX0.0%

PMVP0.0%

Interest Coverage (TTM)

IMUXN/A

PMVPN/A

Net Debt/EBITDA (TTM)

IMUX0.00x

PMVP0.00x

Beta

IMUX1.47

PMVP1.48

52W Performance

IMUX-8.8%

PMVP7.0%

YTD Performance

IMUX40.5%

PMVP23.6%

% from 52W High

IMUX-53.0%

PMVP-20.4%

% from 52W Low

IMUX61.9%

PMVP49.0%

Asset Turnover (TTM)

IMUX0.00x

PMVP0.00x

FCF Yield (TTM)

IMUX-78.9%

PMVP-87.9%

Earnings Yield (TTM)

IMUX-100.0%

PMVP-92.8%

Dividend Yield (TTM)

IMUXN/A

PMVPN/A

Rule of 40

IMUX0.0

PMVP0.0

EV/GP/RG

IMUXN/A

PMVPN/A

Ticker research

View IMUX research View PMVP research

Metric	IMUX Immunic Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$112M	$81M
Enterprise Value	$-44M	$69M
Price	$8.19	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	0.49x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.4%	546.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-112M	$-75M
FCF (TTM)	$-88M	$-71M
EPS (TTM)	-$2.62	-$1.41
ROE (TTM)	-9567.0%	-7811.0%
ROA (TTM)	-10788.0%	-7013.0%
ROIC (TTM)	-9567.0%	-7811.0%
Financial Health
Cash	$155M	$12M
Debt	$0	$0
Net Cash/Debt	$155M	$12M
Current Ratio (TTM)	5.05x	7.70x
Quick Ratio (TTM)	5.00x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.47	1.48
52W Performance	-8.8%	7.0%
YTD Performance	40.5%	23.6%
% from 52W High	-53.0%	-20.4%
% from 52W Low	61.9%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-78.9%	-87.9%
Earnings Yield (TTM)	-100.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUX research	View PMVP research